Zhanwang Xu

1.0k total citations
44 papers, 780 citations indexed

About

Zhanwang Xu is a scholar working on Molecular Biology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Zhanwang Xu has authored 44 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Rheumatology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Zhanwang Xu's work include Bone Metabolism and Diseases (11 papers), Osteoarthritis Treatment and Mechanisms (7 papers) and Spine and Intervertebral Disc Pathology (5 papers). Zhanwang Xu is often cited by papers focused on Bone Metabolism and Diseases (11 papers), Osteoarthritis Treatment and Mechanisms (7 papers) and Spine and Intervertebral Disc Pathology (5 papers). Zhanwang Xu collaborates with scholars based in China, United States and United Kingdom. Zhanwang Xu's co-authors include Nianhu Li, Zhichao Li, Shang‐You Yang, Paul H. Wooley, Dandan Li, Shigui Yan, Weiqi Yan, Kerong Dai, Wenxiang Cheng and Peng Zhang and has published in prestigious journals such as Experimental Cell Research, European Journal of Pharmacology and Pharmacological Research.

In The Last Decade

Zhanwang Xu

40 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhanwang Xu China 13 429 131 116 104 104 44 780
Yongjian Zhao China 19 472 1.1× 146 1.1× 79 0.7× 81 0.8× 125 1.2× 54 897
Franziska Busch Germany 7 405 0.9× 155 1.2× 126 1.1× 57 0.5× 107 1.0× 10 1.0k
Hongfeng Ruan China 18 466 1.1× 147 1.1× 102 0.9× 138 1.3× 86 0.8× 61 911
Chengliang Wu China 16 370 0.9× 189 1.4× 68 0.6× 120 1.2× 74 0.7× 44 792
Shudong Chen China 13 297 0.7× 88 0.7× 65 0.6× 150 1.4× 74 0.7× 27 609
Peijian Tong China 19 443 1.0× 325 2.5× 144 1.2× 76 0.7× 95 0.9× 55 868
Keming Chen China 20 585 1.4× 101 0.8× 116 1.0× 99 1.0× 122 1.2× 64 1.2k
Sik‐Won Choi South Korea 16 527 1.2× 71 0.5× 127 1.1× 57 0.5× 222 2.1× 46 788
Jianbo He China 14 571 1.3× 74 0.6× 137 1.2× 94 0.9× 205 2.0× 16 866
Liaojun Sun China 16 341 0.8× 200 1.5× 96 0.8× 146 1.4× 48 0.5× 26 686

Countries citing papers authored by Zhanwang Xu

Since Specialization
Citations

This map shows the geographic impact of Zhanwang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanwang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanwang Xu more than expected).

Fields of papers citing papers by Zhanwang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhanwang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanwang Xu. The network helps show where Zhanwang Xu may publish in the future.

Co-authorship network of co-authors of Zhanwang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhanwang Xu. A scholar is included among the top collaborators of Zhanwang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhanwang Xu. Zhanwang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Zhanwang, et al.. (2025). The relationship between non-HDL-C/HDL-C ratio and bone mineral density: an NHANES study. Frontiers in Nutrition. 11. 1486370–1486370. 1 indexed citations
2.
3.
Wu, Yan, et al.. (2025). Osteocytes: master orchestrators of skeletal homeostasis, remodeling, and osteoporosis pathogenesis. Frontiers in Cell and Developmental Biology. 13. 1670716–1670716.
4.
Li, Zhichao, Dandan Li, Zhanwang Xu, et al.. (2024). Cell life-or-death events in osteoporosis: All roads lead to mitochondrial dynamics. Pharmacological Research. 208. 107383–107383. 6 indexed citations
5.
Su, Hui, Jun Dong, Zhihui Yan, et al.. (2024). Gu Sui Bu (Drynaria fortunei J. Smith) prevents osteoporosis in ovariectomized rats by inhibiting pyroptosis through NLRP3/GSDMD/CASPASE-1. Pharmacological Research - Modern Chinese Medicine. 13. 100544–100544.
6.
Li, Nianhu, Zhichao Li, Changjun Tie, et al.. (2024). Magnetic resonance imaging classification in a percutaneous needle injury rat model of intervertebral disc degeneration. Journal of Orthopaedic Surgery and Research. 19(1). 632–632. 3 indexed citations
7.
Su, Hui, et al.. (2024). Discovery of potential ferroptosis and osteoporosis biomarkers through TMT proteomics and bioinformatics analysis. BioMedical Engineering OnLine. 23(1). 120–120. 2 indexed citations
8.
9.
Li, Zhichao, Wenxiang Cheng, Dandan Li, et al.. (2024). Pyroptosis: A spoiler of peaceful coexistence between cells in degenerative bone and joint diseases. Journal of Advanced Research. 71. 227–262. 9 indexed citations
10.
Su, Hui, et al.. (2023). Proteomic Analysis Based on TMT Regarding the Therapeutic Action ofRhizoma Drynariae on Rats in an Osteoporosis Model. Combinatorial Chemistry & High Throughput Screening. 27(15). 2223–2238. 2 indexed citations
11.
Li, Zhichao, et al.. (2022). Cell death regulation: A new way for natural products to treat osteoporosis. Pharmacological Research. 187. 106635–106635. 115 indexed citations
12.
Su, Hui, Haipeng Xue, Shang Gao, et al.. (2022). Effect of Rhizoma Drynariae on differential gene expression in ovariectomized rats with osteoporosis based on transcriptome sequencing. Frontiers in Endocrinology. 13. 930912–930912. 3 indexed citations
13.
Gan, Donghao, Wenxiang Cheng, Antonia RuJia Sun, et al.. (2022). Biphasic Effect of Pirfenidone on Angiogenesis. Frontiers in Pharmacology. 12. 804327–804327. 12 indexed citations
14.
Li, Zhichao, et al.. (2022). Exosomes and exosomal miRNAs: A new therapy for intervertebral disc degeneration. Frontiers in Pharmacology. 13. 992476–992476. 18 indexed citations
15.
16.
Wang, Weiguo, et al.. (2014). Protective effects of Vitamin C against spinal cord injury-induced renal damage through suppression of NF-κB and proinflammatory cytokines. Neurological Sciences. 36(4). 521–526. 18 indexed citations
17.
Xu, Zhanwang, et al.. (2013). Naringin promotes osteoblast differentiation and effectively reverses ovariectomy-associated osteoporosis. Journal of Orthopaedic Science. 18(3). 478–485. 75 indexed citations
18.
19.
Yang, Shang‐You, et al.. (2013). Therapeutic potentials of naringin on polymethylmethacrylate induced osteoclastogenesis and osteolysis, in vitro and in vivo assessments. Drug Design Development and Therapy. 8. 1–1. 31 indexed citations
20.
Xu, Zhanwang, et al.. (2008). XLINICAL STUDY ON COMPATIBILITY OF RABBIT MARROW STROMA CELLS AND BIOLOGICAL ACTIVITY GLASS FRAME. 20(1). 9–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongjian Zhao Breakdown of academic impact, for papers by Franziska Busch Breakdown of academic impact, for papers by Hongfeng Ruan Breakdown of academic impact, for papers by Chengliang Wu Breakdown of academic impact, for papers by Shudong Chen Breakdown of academic impact, for papers by Peijian Tong Breakdown of academic impact, for papers by Keming Chen Breakdown of academic impact, for papers by Sik‐Won Choi Breakdown of academic impact, for papers by Jianbo He Breakdown of academic impact, for papers by Liaojun Sun
Rankless by CCL
2026